Sheng Li
- Oncology top 10%
- Molecular Biology
- Cancer Research top 10%
- Pulmonary and Respiratory Medicine
- Immunology
- Topics
- Cancer Cells and Metastasis (8 papers)Pancreatic and Hepatic Oncology Research (7 papers)AI in cancer detection (5 papers)
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Sheng Li
54 papers receiving 773 citations
Peers
Comparison fields: 5 of 101
- Oncology 425
- Molecular Biology 235
- Cancer Research 160
- Pulmonary and Respiratory Medicine 120
- Immunology 104
Countries citing papers authored by Sheng Li
This map shows the geographic impact of Sheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Li more than expected).
Fields of papers citing papers by Sheng Li
This network shows the impact of papers produced by Sheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Li. The network helps show where Sheng Li may publish in the future.
Co-authorship network of co-authors of Sheng Li
This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Li. A scholar is included among the top collaborators of Sheng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Li. Sheng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 21 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 9 | |
| 8 | 1 | |
| 9 | 7 | |
| 10 | 3 | |
| 11 | 19 | |
| 12 | 20 | |
| 13 | 17 | |
| 14 | 9 | |
| 15 | 22 | |
| 16 | 15 | |
| 17 | 11 | |
| 18 | 3 | |
| 19 | 29 | |
| 20 | 23 |
About Sheng Li
Sheng Li is a scholar working on Oncology, Cancer Research and Pharmacy, having authored 57 papers that have together received 786 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and AI in cancer detection (5 papers). The work is most often cited by research in Oncology (425 citations), Cancer Research (160 citations) and Hepatology (46 citations). Sheng Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Kai Cui, Jianbo Zhang, Bo Zhang, Wuyuan Zhou, Wenhua Zhao, Ailiang Wang, Yang Ou, Dan Tan, Dechang Chen and Donald E. Henson. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.